Summary
Cannot evaluate on-label alignment because the AI response does not provide any specific claim text to map to the FDA label; multiple conclusions ('absent_from_the_label') are not verifiable from the provided information.
Category Scores
Accurate Statements
The label excerpts provided indicate ARAKODA is indicated for prophylaxis of malaria in patients aged 18 years and older.
Section 1 (Indications and Usage): 'ARAKODA is indicated for the prophylaxis of malaria in patients aged 18 years and older.'
Unsupported Statements
The claim to evaluate is 'absent_from_the_label' (and associated fields like supported_by_label=false/contradicted_by_label=false/partial_support=false).
No exact claim text was provided, so the determination 'absent_from_the_label' is not supported by the supplied prompt information.
The response states or implies an inability to evaluate without claim text, while also giving an evaluation outcome ('absent_from_the_label').
These are inconsistent: if the claim cannot be assessed, an 'absent_from_the_label' conclusion cannot be substantiated from the label excerpts or the missing claim text.
Off-label/plausibility determinations: 'off_label_but_plausible=false'.
No claim text is provided, so off-label versus on-label plausibility cannot be established from the label excerpts alone.
Specific 'dangerous_omissions_check' items such as 'boxed_warnings: unknown' and 'contraindications: cannot assess—no claim text' without tying to any provided claim text.
The check is not grounded to a specific medical/benefit-safety claim; therefore it does not meaningfully evaluate label alignment.
Contradictions
Low
AI Statement
The response’s stated evaluation outcome ('absent_from_the_label') conflicts with the earlier acknowledgement that the claim text is not provided and cannot be assessed.
Label Reference
N/A (no claim text provided; contradiction is internal to the response rather than directly against label text).
Important Omissions
The exact AI-generated claim text that was purportedly evaluated.
Importance:
High
Any direct mapping from a specific claim to specific FDA label sentences (e.g., for hemolytic anemia, methemoglobinemia, psychiatric effects, contraindications, dosing/administration, or drug interactions).
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Because the response provides an unverified determination ('absent_from_the_label') without the claim text and without label mapping, it could mislead downstream decisions about safety/label alignment.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Evaluation outcome given without the claim text; unsupported/unverifiable conclusion.
Suggested Improvement
Provide the exact claim text to evaluate, then cite the specific FDA label section(s) and sentence(s) supporting, partially supporting, or contradicting it.